Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Twist Bioscience Corp
Report date October 24, 2019 · Filed November 06, 2019
Section 16 reporting ended · disclosed 2019-11-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,346 |
Reported balance
After 2019-10-24 transaction · row 1
1 source rowRow 1 · 2019-10-24 · Grant · Acquired 7,410 · Balance 20,346 F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2029-10-23 | Direct | 31,770 |
Reported balance
After 2019-10-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-10-24 · Grant · Acquired 31,770 · Balance 31,770 F2: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2019 Filed Nov 6, 2019 02:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 31,770 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001209191-19-055409 · doc4.xml · derivative · entry 2 Kunz Martin · CIK 0001766597 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,770 Underlying: Common Stock · 31,770 shares Expires 2029-10-23 F2 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 7,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055409 · doc4.xml · nonDerivative · entry 1 Kunz Martin · CIK 0001766597 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,346 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 60,371 | $0.00 Strike: $23.19 | $0.00 |
DisclosureSEC source: 0001209191-19-007422 · doc4.xml · derivative · entry 2 Kunz Martin · CIK 0001766597 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,371 Underlying: Common Stock · 60,371 shares Expires 2029-02-03 F2 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on February 4, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 12,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007422 · doc4.xml · nonDerivative · entry 1 Kunz Martin · CIK 0001766597 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,936 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on February 4, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.